Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 85.98
(-20.0%)
CNY 85.98
(-20.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 936.19 Million CNY | 61.55% |
| 2022 | 579.49 Million CNY | 33.81% |
| 2021 | 433.07 Million CNY | 58.61% |
| 2020 | 273.04 Million CNY | 39.88% |
| 2019 | 195.19 Million CNY | 53.73% |
| 2018 | 126.97 Million CNY | 69.72% |
| 2017 | 74.81 Million CNY | 71.86% |
| 2016 | 43.52 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 308.96 Million CNY | 10.59% |
| 2024 Q2 | 370.47 Million CNY | 19.91% |
| 2023 Q1 | 189.79 Million CNY | 37.35% |
| 2023 FY | 936.19 Million CNY | 61.55% |
| 2023 Q4 | 279.36 Million CNY | 6.94% |
| 2023 Q3 | 261.25 Million CNY | 20.36% |
| 2023 Q2 | 217.05 Million CNY | 14.37% |
| 2022 FY | 579.49 Million CNY | 33.81% |
| 2022 Q4 | 138.18 Million CNY | -17.91% |
| 2022 Q3 | 168.33 Million CNY | 18.81% |
| 2022 Q2 | 141.68 Million CNY | 7.92% |
| 2022 Q1 | 131.29 Million CNY | 21.37% |
| 2021 Q1 | 84.4 Million CNY | -7.78% |
| 2021 Q3 | 118.6 Million CNY | -2.68% |
| 2021 Q2 | 121.87 Million CNY | 44.39% |
| 2021 Q4 | 108.17 Million CNY | -8.8% |
| 2021 FY | 433.07 Million CNY | 58.61% |
| 2020 Q3 | 77.93 Million CNY | 0.74% |
| 2020 Q1 | 26.21 Million CNY | -52.56% |
| 2020 FY | 273.04 Million CNY | 39.88% |
| 2020 Q4 | 91.53 Million CNY | 17.44% |
| 2020 Q2 | 77.36 Million CNY | 195.14% |
| 2019 Q4 | 55.25 Million CNY | 22.13% |
| 2019 FY | 195.19 Million CNY | 53.73% |
| 2019 Q3 | 45.24 Million CNY | -12.34% |
| 2019 Q2 | 51.61 Million CNY | 19.81% |
| 2019 Q1 | 43.07 Million CNY | 13.65% |
| 2018 Q4 | 37.9 Million CNY | 0.0% |
| 2018 FY | 126.97 Million CNY | 69.72% |
| 2017 FY | 74.81 Million CNY | 71.86% |
| 2016 FY | 43.52 Million CNY | 0.0% |